细胞穿透伴侣肽Nuc1用于小分子和大分子向视网膜细胞及组织的递送
本研究设计了一种基于硫酸乙酰肝素蛋白聚糖和核仁素结合序列的新型肽Nuc1,无需偶联即可将类固醇、肽、抗体、重组蛋白和AAV递送入视网膜细胞。小鼠玻璃体内注射后,Nuc1通过巨胞饮进入细胞,增强抗VEGF抗体(玻璃体内或局部)和decorin的递送,抑制视网膜凋亡、新生血管和纤维化,并增强AAV经视网膜下和玻璃体内途径的视网膜穿透。
要点
- Nuc1肽无需与载荷偶联即可递送小分子和大分子跨越生物膜进入视网膜。
- Nuc1通过巨胞饮过程进入细胞。
- Nuc1增强抗VEGF抗体、decorin和AAV在AMD模型中的视网膜递送和功能。
核心结论
- Nuc1作为新型递送方法,在将重组蛋白递送入视网膜细胞方面显示出前景。
研究设计与样本
- 基于已知结合硫酸乙酰肝素蛋白聚糖和视网膜细胞表面核仁素的序列设计Nuc1肽。
- 将Nuc1与多种分子一起注射到小鼠玻璃体内,检查视网膜对这些分子的摄取和功能。
主要发现
- Nuc1通过巨胞饮过程进入细胞。
- 经玻璃体内注射途径,Nuc1将功能性重组X连锁凋亡抑制蛋白递送至光感受器,抑制视网膜凋亡。
- 在年龄相关性黄斑变性(AMD)模型中,Nuc1增强玻璃体内或局部递送的抗VEGF抗体的递送。
- Nuc1增强decorin的递送,在AMD模型中显著抑制新生血管和纤维化。
- Nuc1增强AAV经视网膜下和玻璃体内注射途径对 retinal 细胞和组织的穿透。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: There are currently no means available for the efficient delivery of recombinant proteins into retinal cells in vivo. Although cell-penetrating peptides have been somewhat effective in protein delivery to the retina, they generally require conjugation chemistry with the payload, negatively impacting function of the therapeutic protein. In this study, we developed a novel peptide (Nuc1) that acts as a chaperone for delivery of small and large molecules, including steroids, peptides, antibodies, recombinant proteins, and viruses (adeno-associated viruses [AAVs]) across biological membranes in vivo without the need for conjugation. METHODS: Nuc1 peptide was designed based on sequences known to bind heparan sulfate proteoglycans and nucleolin found on the surface of retinal cells. Nuc1 was injected into the vitreous of mice with a variety of molecules and retinas examined for uptake and function of these molecules. RESULTS: Nuc1 engages the process of macropynocytosis for cell entry. The delivery of functional recombinant X-linked inhibitor of apoptosis protein to photoreceptors via the intravitreal route of injection inhibited retinal apoptosis. Nuc1 was found to enhance the delivery of anti-VEGF antibodies delivered intravitreally or topically in models of age-related macular degeneration (AMD). Nuc1 enhanced delivery of decorin, facilitating significant inhibition of neovascularization and fibrosis in a model of AMD. Finally, Nuc1 was found to enhance penetration of retinal cells and tissues by AAV via both the subretinal and intravitreal routes of injection. CONCLUSIONS: Nuc1 shows promise as a novel approach for the delivery of recombinant proteins into retinal cells in vivo.
引用
- Kumar B, Mishra M, Talreja D, et al. Cell-Penetrating Chaperone Nuc1 for Small- and Large-Molecule Delivery Into Retinal Cells and Tissues. Invest Ophthalmol Vis Sci. 2024. PMID: 39028980. doi:10.1167/iovs.65.8.31
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。